WHO ICTRP trial

Non-interventional study on Therapeutic Drug Monitoring (TDM) in patients with…

DRKS00025325 · German Clinical Trials Register · Recruiting

Key facts

Trial ID DRKS00025325
Public title Non-interventional study on Therapeutic Drug Monitoring (TDM) in patients with renal cell carcinoma and on the feasibility of using Volumetric Absorptive Microsampling (VAMS) for sample collection (ON-TARGET)
Scientific title Non-interventional study on Therapeutic Drug Monitoring (TDM) in patients with renal cell carcinoma and on the feasibility of using Volumetric Absorptive Microsampling (VAMS) for sample collection (ON-TARGET) - ON-TARGET
Primary sponsor Central European Society for Anticancer Drug Research (CESAR) e.V.
Registry German Clinical Trials Register
Recruitment status Recruiting
Study type observational
Countries Germany
Conditions C64;Malignant neoplasm of kidney, except renal pelvis
Interventions Group 1: Patients participating in the study will have a venous and (an optional additional) capillary blood sample taken as part of their regular follow-up visits. The concentration of the drug (axitinib or cabozantinib) in the blood…
Registration date Jun 16, 2021
Target size 80
Registry page drks.de

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations